Monitoring of motor pathways via muscle contraction recording is sensitive
to anesthetics, particularly volatile anesthetics. However, the specific ac
tion sites of these anesthetics on the spinal cord and the peripheral nervo
us system are not well known in humans. Therefore, we studied proximal and
distal motor and sensory nerve conduction, neuromuscular junction transmiss
ion, and spinal cord excitability (H/M amplitude ratio and F-wave amplitude
and persistency) using standard neurophysiological techniques in 10 patien
ts who underwent orthopedic surgery. Muscle potentials evoked by spinal cor
d stimulation were recorded in five additional patients. Desflurane was int
roduced to achieve end-tidal concentration of 3.7% and 7.4%, in 50% O-2/N2O
and in 100% O-2. Measurements were obtained before desflurane administrati
on and 20 min after obtaining a stable level of each concentration. Periphe
ral nerve conduction and neuromuscular function were not significantly affe
cted by desflurane. However, spinal cord excitability was significantly dec
reased by desflurane administration (H/M ratio 37% +/- 9%, 12% +/- 5%, 7% /- 4% at desflurane concentration 0.0%, 3.7%, and 7.4% in 100% O-2 respecti
vely). Muscle potentials evoked by spinal cord stimulation were abolished b
y desflurane. These data rule out the possibility that desflurane specifica
lly alters peripheral nerve conduction or synapse transmission at the neuro
muscular junction. They demonstrate that desflurane acts preferentially at
the level of the spinal motoneuron. Implications: We used neurophysiologica
l techniques to assess the effects of desflurane on spinal cord conduction
and excitability, motor and sensory peripheral nerve conduction, and neurom
uscular transmission. Our data demonstrate that desflurane acts preferentia
lly at the level of the spinal motoneuron, providing useful information for
neurophysiological monitoring and immobilization during surgery and for mi
nimum alveolar anesthetic concentration definition.